[144] Arteris, Inc. SEC Filing

Rhea-AI Filing Summary

Notice of proposed insider sale: This Form 144 reports a planned sale of 17,200 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $188,856.00. The shares were acquired as Restricted Stock Units on 09/03/2024 and listed as available for sale with an approximate sale date of 10/06/2025 on NASDAQ. The filing also discloses multiple recent sales by the same person under 10b5-1 plans totaling tens of thousands of shares across 07/29/2025 through 10/03/2025, with individual gross proceeds shown per trade. The filer represents they know of no undisclosed material adverse information.

Positive

• Full disclosure of broker and trade details including broker name and per-trade gross proceeds
• Planned sale is of RSUs acquired on 09/03/2024, indicating these were compensation-related shares rather than opportunistic market purchases
• Multiple prior sales executed under 10b5-1 plans show the holder is using pre-arranged plans to manage insider sales

Negative

• Significant recent insider selling (multiple transactions totaling tens of thousands of shares) could exert near-term downward pressure on the stock
• Aggregate shares to be sold represent a non-trivial position relative to the outstanding share count of 42,649,917, increasing supply risk

Insights

Insider Transaction Specialist

Planned sale of RSUs reflects routine insider liquidity, not compensation change.

The filing shows 17,200 shares from Restricted Stock Units acquired on 09/03/2024 are being registered for sale through a broker, with an aggregate market value of $188,856.00. This is a standard notice that allows the holder to sell once conditions under Rule 144 are met.

Recent 10b5-1 sales listed across 07/29/2025–10/03/2025 indicate an ongoing systematic selling pattern. Monitor short-term share count changes and reported proceeds in regular filings over the next 30–90 days for incremental dilution effects.

Corporate Governance Analyst

Disclosure aligns with Rule 144 and 10b5-1 plan mechanics; no governance red flags shown.

The notice includes the required representation that the seller is unaware of undisclosed material adverse information and documents prior planned sales executed under 10b5-1. Details include broker identity and specific trade amounts, supporting transparency of insider liquidity.

Key items to watch are any subsequent amendments or Form 4 filings that report additional sales or confirm completion of the proposed sale within the stated timeframe.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	17200	188856.00	42649917	10/06/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/03/2024	Restricted Stock Units	Issuer			17200	09/03/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales Plan for LAURENT MOLL 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	10/03/2025	1554	17228.60
10b5-1 Sales Plan for LAURENT MOLL 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	10/02/2025	19060	209484.65
LAURENT MOLL 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	10/02/2025	4702	51349.60
10b5-1 Sales Plan for LAURENT MOLL 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	09/09/2025	151	1300.11
10b5-1 Sales Plan for LAURENT MOLL 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	09/08/2025	8129	71075.10
10b5-1 Sales Plan for LAURENT MOLL 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	09/05/2025	4698	41363.54
LAURENT MOLL 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	09/02/2025	42692	381739.06
10b5-1 Sales Plan for LAURENT MOLL 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	08/05/2025	34400	466763.28
10b5-1 Sales Plan for LAURENT MOLL 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	07/29/2025	736	8022.40

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for AIP mean?

It notifies the SEC of a proposed sale of 17,200 AIP common shares valued at $188,856.00, allowing the seller to comply with Rule 144 resale requirements.

When were the shares being sold acquired for AIP?

The shares were acquired as Restricted Stock Units on 09/03/2024.

Who is the broker handling the proposed AIP sale?

The broker listed is Morgan Stanley Smith Barney LLC at 1 New York Plaza, New York, NY.

Has the insider recently sold AIP shares?

Yes; the filing lists multiple 10b5-1 plan sales between 07/29/2025 and 10/03/2025, with individual gross proceeds shown for each trade.

What exchange will the AIP shares be sold on?

The proposed sale is listed for NASDAQ with an approximate sale date of 10/06/2025.